These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34756525)

  • 21. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analyses of sacubitril-valsartan for heart failure.
    Liu XQ; He LS; Huang JQ; Xiong LJ; Xia C; Lao HY
    Heart Fail Rev; 2021 Sep; 26(5):1119-1130. PubMed ID: 32405811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 24. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore.
    Chua WB; Cheen HH; Kong MC; Chen LL; Wee HL
    Int J Clin Pharm; 2016 Oct; 38(5):1230-40. PubMed ID: 27461367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.
    Permsuwan U; Dilokthornsakul P; Thavorn K; Saokaew S; Chaiyakunapruk N
    J Med Econ; 2017 Feb; 20(2):171-181. PubMed ID: 27645706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.
    Kantito S; Saokaew S; Yamwong S; Vathesatogkit P; Katekao W; Sritara P; Chaiyakunapruk N
    J Thromb Thrombolysis; 2018 Feb; 45(2):281-290. PubMed ID: 29181693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A telemonitoring programme in patients with heart failure in France: a cost-utility analysis.
    Caillon M; Sabatier R; Legallois D; Courouve L; Donio V; Boudevin F; de Chalus T; Hauchard K; Belin A; Milliez P
    BMC Cardiovasc Disord; 2022 Oct; 22(1):441. PubMed ID: 36217130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
    Pandor A; Thokala P; Gomersall T; Baalbaki H; Stevens JW; Wang J; Wong R; Brennan A; Fitzgerald P
    Health Technol Assess; 2013 Aug; 17(32):1-207, v-vi. PubMed ID: 23927840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    Aungsumart S; Apiwattanakul M
    PLoS One; 2020; 15(2):e0229028. PubMed ID: 32050011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
    Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P
    Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients.
    Aspinall SL; Smith KJ; Good CB; Zhao X; Stone RA; Tonnu-Mihara IQ; Cunningham FE
    Appl Health Econ Health Policy; 2013 Dec; 11(6):653-60. PubMed ID: 24092553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of a Multicomponent Intervention for Hypertension Control in Low-Income Settings in Argentina.
    Zhang Y; Yin L; Mills K; Chen J; He J; Palacios A; Riviere AP; Irazola V; Augustovski F; Shi L
    JAMA Netw Open; 2021 Sep; 4(9):e2122559. PubMed ID: 34519769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
    Sanyal C; Turner JP; Martin P; Tannenbaum C
    J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a Heart Failure Telemonitoring Program Through a Microsimulation Model: Cost-Utility Analysis.
    Boodoo C; Zhang Q; Ross HJ; Alba AC; Laporte A; Seto E
    J Med Internet Res; 2020 Oct; 22(10):e18917. PubMed ID: 33021485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Utility of Video-Electroencephalography Monitoring Followed by Surgery in Adults with Drug-Resistant Focal Epilepsy in Thailand.
    Kitwitee P; Unnwongse K; Srikijvilaikul T; Yadee T; Limwattananon C
    World Neurosurg; 2017 Feb; 98():750-760.e3. PubMed ID: 27913266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-utility analysis of dasatinib and nilotinib in patients with chronic myeloid leukemia refractory to first-line treatment with imatinib in Thailand.
    Kulpeng W; Sompitak S; Jootar S; Chansung K; Teerawattananon Y
    Clin Ther; 2014 Apr; 36(4):534-43. PubMed ID: 24635968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand.
    Kotirum S; Chongmelaxme B; Chaiyakunapruk N
    J Thromb Thrombolysis; 2017 Feb; 43(2):252-262. PubMed ID: 27704332
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.